Latest filing published 08 Nov 2010 for HAEMONETICS CORP, €7,052.
No signal scores available.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Michael I. Ruxin has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Global Med Technologies Inc and Haemonetics Corp. The record holds 13 filings, for trades running from 3 October 2005 to 4 November 2010.
Market trades split into 4 purchases (€9,412) and 1 sale (€205k). Sales outweigh purchases by €195k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 2 option exercises. In 2010 alone, the filings show 1 purchase and no sales.
In size, the median ticket on the buying side is €797.
The record was last updated on 8 November 2010 with an open-market purchase (€7,052) in Haemonetics Corp. The median gap between a trade and its publication by SEC (Form 4) is 3 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations